TransCode Therapeutics CEO Letter to Shareholders
BOSTON, July 05, 2023 -- Dear TransCode Therapeutics Shareholders, I want to express the optimism that permeates the management, board, and staff of TransCode as we navigate the ever-evolving...
Source: marketscreener.com